ViBo Health develops the DigiScan™, a non-invasive finger scanner that utilizes molecular spectroscopy to quickly detect multiple biomarkers associated with pre-diabetes, providing instant results in just 10 seconds. This technology addresses the challenge of late diagnosis in preventable diseases by making early detection accessible in high-traffic locations like gyms and pharmacies.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
A significant portion of the population suffers from preventable diseases like pre-diabetes, but current screening methods are often ineffective, cumbersome, and inaccessible, leading to late diagnoses. Traditional blood tests, the most reliable method for pre-diabetes detection, require specialist personnel, are performed in clinical settings, and are often administered only after symptoms appear. This results in a large percentage of individuals with pre-diabetes remaining undiagnosed, increasing healthcare costs and negatively impacting individual health outcomes.
Solution
ViBo Health is developing the DigiScan™, a non-invasive finger scanner that utilizes molecular spectroscopy to provide a quick and accessible method for early disease detection. The DigiScan™ aims to disrupt the conventional disease detection model by offering a pain-free alternative to blood draws with instant results in just 10 seconds. By detecting multiple biomarkers associated with pre-diabetes, the device enables early intervention and prevention strategies. The device is intended for use in high-traffic locations such as gyms, pharmacies, and workplaces, making early detection more convenient and accessible to a wider population.
Target Audience
The primary target audience includes individuals at risk of developing pre-diabetes, employers looking to reduce healthcare costs, and healthcare providers seeking a more efficient and accessible screening tool.
Features
- Non-invasive finger scan using molecular spectroscopy
- Detects multiple biomarkers validated for pre-diabetes identification, including glucose variability, insulin, A1C, lipid changes, lactate, and CRP
- Provides instant results in 10 seconds
- Compact size, similar to a breadbox, for easy placement in various locations
- Intended for use in accessible locations like gyms, pharmacies, and workplaces